Clinical trial registry record

Ursolic Acid-Standardized Apple Pomace Supplementation for Muscle Strength and Physical Performance in Older Adults With Mild Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Trial

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated September 2, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07562698
Last registry update
September 2, 2026
Status
Completed
Phase
Phase not reported
Sponsor
Liaquat University of Medical & Health Sciences
Enrollment
105
Countries
Pakistan
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · SUPPORTIVE CARE · QUADRUPLE
Evidence population
Human clinical study registration
Participants
105
Population
ALL · 65 Years to 80 Years
Duration
2026-05-10 to 2026-08-31
Intervention
Ursolic Acid-Standardized Apple Pomace Extract; Placebo
Comparator
Placebo
Outcomes measured
Change in handgrip strength from baseline — Baseline to Week 12; Change in five-times chair stand test time — Baseline to Week 12; Change in Short Physical Performance Battery (SPPB) score — Baseline to Week 12; Change in gait speed — Baseline to Week 12; Change in Timed Up and Go test time — Baseline to Week 12; Change in body composition — Baseline to Week 12; Change in fatigue severity — Baseline to Week 12; Change in health-related quality of life — Baseline to Week 12
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Sarcopenia · 100%Title contains controlled term: sarcopenia. Abstract contains controlled term: sarcopenia. Source terminology contains: sarcopenia. Title supplies longevity context: older adult. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

sarcopenia
Open primary sourceExport JSON